Find Clinical Trial

Home » Find Clinical Trials » Safety and efficacy of S 38093 and donepezil, during 4 weeks, in patients with mild to moderate Alzheimer’s Disease. An international, multi-centre, randomised, double-blind, placebo controlled, phase II add-on study

Safety and efficacy of S 38093 and donepezil, during 4 weeks, in patients with mild to moderate Alzheimer’s Disease. An international, multi-centre, randomised, double-blind, placebo controlled, phase II add-on study

← Back

Study Phase	Phase 2

Therapeutic Area	Neuropsychiatric Diseases

Indication	Alzheimer's disease

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	S038093

Active Substance Code	S038093

Protocol Code	CL2-38093-009

EudraCT Code	2009-012035-15

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.